Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The potential of epigenetic therapies in neurodegenerative diseases.
Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease.
Deletion of caspase-8 in mouse myeloid cells blocks microglia pro-inflammatory activation and confers protection in MPTP neurodegeneration model.
The Nogo/ Nogo-66 receptor (NgR) signal is involved in neuroinflammation through the regulation of microglia inflammatory mediator expression.
Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review.
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
Neurological disorders and celiac disease.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
Subretinal angiostrongyliasis-induced optic neuritis.
Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME.
[Analysis of a series of cases with an initial diagnosis of acute disseminated encephalomyelitis over the period 2000-2010].
Outcomes after Microvascular Decompression for Patients with Trigeminal Neuralgia and Suspected Multiple Sclerosis.
Protein-protein interaction analysis highlights additional Loci of interest for multiple sclerosis.
Targeting the B7 Family of Co-Stimulatory Molecules : Successes and Challenges.
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
The Relationship Between Balance Confidence and Cognitive Motor Interference in Individuals With Multiple Sclerosis.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
[Oral treatments in multiple sclerosis].
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
Association between chronic stress-induced structural abnormalities in Ranvier nodes and reduced oligodendrocyte activity in major depression.
Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.

Pages